CAP-IT CRI U54 ADMINISTRATIVE CORE
CAP-IT CRI U54 ADMINISTRATIVE CORE
批准号:
10505676
负责人:
Steven M Lipkin
金额:
$11.71万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-08-31
关键词:
American Association of Cancer ResearchAmerican Society of Clinical OncologyAutomobile DrivingAwardCancer CenterCancer Research ProjectClinicalClinical TrialsCollaborationsContractsDana-Farber Cancer InstituteDatabase Management SystemsDatabasesDivision of Cancer PreventionDoctor of PhilosophyEmerging TechnologiesEnsureEvaluationGenetic DatabasesGenomicsGoalsHealth Insurance Portability and Accountability ActHereditary Nonpolyposis Colorectal NeoplasmsIACUCImmune TargetingImmunooncologyImmunopreventionIndividualInstitute of Medicine (U.S.)Institutional Review BoardsInternationalJournalsLeadLeadershipMalignant neoplasm of lungMedicineMissionNational Cancer InstitutePatientsPrevention ResearchProductivityProgram Research Project GrantsRNARNA vaccineResearchResearch PersonnelResearch Project GrantsResource SharingRoleSiteTimeTranslatingTranslationsVaccinesValidationarchive datacancer preventioncancer riskclinical translationdata archivedata managementdata sharingeditorialexperienceindividualized preventionmeetingsmemberpre-clinicalprogramstargeted agenttumor immunologyworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Admin Core: Project Summary/Abstract
A significant overall goal of CAP-IT is to identify and validate immunologically targeted agents for precision
prevention of individuals with increased cancer risk. The CAP-IT Center for RNA Immunoprevention (CRI)
Administrative Core (AC) mission is to ensure that research project/Core teams maintain focus on this overall
goal. The AC will rapidly perform administrative functions that would otherwise serve as rate-limiting bottlenecks,
including IRB/IACUC regulatory compliance and the establishment of MTA/DTAs between multiple project sites.
The AC will integrate CRI U54 into the CAP-IT network and drive intra-network as well as international
collaborations. To ensure CRI's scientific rigor and excellence, we have assembled a scientifically and
administratively outstanding CRI External Advisory Board, including the 2021 Lasker Award winner Dr. Drew
Weissman (U. Penn). The AC shall also seamlessly integrate genomic databases and emerging technology as
shared resources (such as liponanoparticle RNA vaccines and immunopeptidomics) with the CAP-IT U24 DRCC.
1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lynch Vaccine
-
批准号:10505678
-
项目类别:
-
资助金额:$44.11万
-
财政年份:2022
-
负责人:Steven M Lipkin
-
依托单位:
Cancer Immune-Interception for Lynch Syndrome
-
批准号:10491665
-
项目类别:
-
资助金额:$66.19万
-
财政年份:2021
-
负责人:Steven M Lipkin
-
依托单位:
Cancer Immune-Interception for Lynch Syndrome
-
批准号:10706565
-
项目类别:
-
资助金额:$66.01万
-
财政年份:2021
-
负责人:Steven M Lipkin
-
依托单位:
Elucidating the Role of MALAT1 Somatic Driver Mutations in Colorectal Cancer
-
批准号:10307526
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
Elucidating the Role of MALAT1 Somatic Driver Mutations in Colorectal Cancer
-
批准号:10056203
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
Neoantigen Vaccination for Lynch Syndrome Immunoprevention
-
批准号:9789215
-
项目类别:
-
资助金额:$71.75万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
Neoantigen Vaccination for Lynch Syndrome Immunoprevention
-
批准号:10478171
-
项目类别:
-
资助金额:$78.03万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
Elucidating the Role of MALAT1 Somatic Driver Mutations in Colorectal Cancer
-
批准号:10532219
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
(PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance
-
批准号:10229450
-
项目类别:
-
资助金额:$50.32万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
Neoantigen Vaccination for Lynch Syndrome Immunoprevention
-
批准号:10240627
-
项目类别:
-
资助金额:$63.81万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
IGF::OT::IGF ANTI FUSOBACTERIUM NUCLEATUM VACCINE FOR COLORECTAL CANCER IMMUNOPREVENTION
-
批准号:9358850
-
项目类别:
-
资助金额:$42.34万
-
财政年份:2016
-
负责人:Steven M Lipkin
-
依托单位:
ANTI FUSOBACTERIUM NUCLEATUM VACCINE FOR COLORECTAL CANCER IMMUNOPREVENTION
-
批准号:10006480
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2016
-
负责人:Steven M Lipkin
-
依托单位:
IGF::OT::IGF ANTI FUSOBACTERIUM NUCLEATUM VACCINE FOR COLORECTAL CANCER IMMUNOPREVENTION
-
批准号:9563035
-
项目类别:
-
资助金额:$47.66万
-
财政年份:2016
-
负责人:Steven M Lipkin
-
依托单位:
IGF::OT::IGF TESTING OF COMBINATION IMMUNO AND CHEMOPREVENTION STRATEGIES FOR LYNCH SYNDROME GASTROINTESTINAL CANCER
-
批准号:9443551
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2015
-
负责人:Steven M Lipkin
-
依托单位:
IGF::OT::IGF TESTING OF COMBINATION IMMUNO AND CHEMOPREVENTION STRATEGIES FOR LYNCH SYNDROME GASTROINTESTINAL CANCER
-
批准号:9162495
-
项目类别:
-
资助金额:$68.0万
-
财政年份:2015
-
负责人:Steven M Lipkin
-
依托单位:
IGF::OT::IGF Base Contract Title: Preclinical In Vitro and In Vivo Agent Development Assays, Task Order Title: A Polyvalent Vaccine Against Fusion Proteins Observed in Solid Tumors, Period of Perfo
-
批准号:8941109
-
项目类别:
-
资助金额:$45.86万
-
财政年份:2014
-
负责人:Steven M Lipkin
-
依托单位:
Using Protein Interactome Networks to Understand the Functional Role of Coding DN
-
批准号:8706913
-
项目类别:
-
资助金额:$41.11万
-
财政年份:2013
-
负责人:Steven M Lipkin
-
依托单位:
Using Protein Interactome Networks to Understand the Functional Role of Coding DN
-
批准号:8431489
-
项目类别:
-
资助金额:$44.88万
-
财政年份:2013
-
负责人:Steven M Lipkin
-
依托单位:
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes
-
批准号:8438623
-
项目类别:
-
资助金额:$39.24万
-
财政年份:2012
-
负责人:Steven M Lipkin
-
依托单位:
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes
-
批准号:8681393
-
项目类别:
-
资助金额:$33.06万
-
财政年份:2012
-
负责人:Steven M Lipkin
-
依托单位:
海外基金